Abstract
Since 2021, Turkmenistan has been vaccinating the population against COVID-19. The aim of the work is a comparative analisis of the effectiveness of vaccines against SARS–CoV-2 used in mass vaccination of the population in the development of population immunity.Research materials. The blood serum of 960 people vaccinated with “Sputnik-lite” or “BIOvac” was used in the work.Conclusion. 3 months after revaccination, 100 % of vaccinated patients have a high level of specific IgG antibodies in their blood serum. A comparative analysis of the effectiveness of two vaccines “Sputnik-lite” and “BIOvac”, showed that a longer immune response persists after the introduction of the vaccine “Sputnik-lite”.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
